Bayabao, Alaizah D.
HRN: 21-95-47 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2022
CIPROFLOXACIN 500MG (TAB)
10/20/2022
10/27/2022
ORAL
120mg/pptab
BID
Hypovolemic Shock Sec To AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes